S&P 500   3,859.18 (+0.10%)
DOW   31,005.34 (+0.15%)
QQQ   329.12 (+0.31%)
AAPL   142.91 (+-0.01%)
MSFT   233.58 (+1.76%)
FB   282.96 (+1.78%)
GOOGL   1,908.93 (+0.77%)
AMZN   3,331.01 (+1.12%)
TSLA   888.62 (+0.89%)
NVDA   539.09 (-1.29%)
BABA   264.12 (+1.05%)
CGC   35.33 (+7.35%)
GE   11.56 (+5.19%)
MU   80.50 (-0.96%)
AMD   94.93 (+0.85%)
NIO   59.71 (-0.47%)
T   29.67 (+1.92%)
F   11.16 (-1.15%)
ACB   10.68 (+5.12%)
BA   202.67 (-0.34%)
DIS   169.83 (-1.20%)
NFLX   560.16 (+0.61%)
GILD   66.66 (-2.20%)
S&P 500   3,859.18 (+0.10%)
DOW   31,005.34 (+0.15%)
QQQ   329.12 (+0.31%)
AAPL   142.91 (+-0.01%)
MSFT   233.58 (+1.76%)
FB   282.96 (+1.78%)
GOOGL   1,908.93 (+0.77%)
AMZN   3,331.01 (+1.12%)
TSLA   888.62 (+0.89%)
NVDA   539.09 (-1.29%)
BABA   264.12 (+1.05%)
CGC   35.33 (+7.35%)
GE   11.56 (+5.19%)
MU   80.50 (-0.96%)
AMD   94.93 (+0.85%)
NIO   59.71 (-0.47%)
T   29.67 (+1.92%)
F   11.16 (-1.15%)
ACB   10.68 (+5.12%)
BA   202.67 (-0.34%)
DIS   169.83 (-1.20%)
NFLX   560.16 (+0.61%)
GILD   66.66 (-2.20%)
S&P 500   3,859.18 (+0.10%)
DOW   31,005.34 (+0.15%)
QQQ   329.12 (+0.31%)
AAPL   142.91 (+-0.01%)
MSFT   233.58 (+1.76%)
FB   282.96 (+1.78%)
GOOGL   1,908.93 (+0.77%)
AMZN   3,331.01 (+1.12%)
TSLA   888.62 (+0.89%)
NVDA   539.09 (-1.29%)
BABA   264.12 (+1.05%)
CGC   35.33 (+7.35%)
GE   11.56 (+5.19%)
MU   80.50 (-0.96%)
AMD   94.93 (+0.85%)
NIO   59.71 (-0.47%)
T   29.67 (+1.92%)
F   11.16 (-1.15%)
ACB   10.68 (+5.12%)
BA   202.67 (-0.34%)
DIS   169.83 (-1.20%)
NFLX   560.16 (+0.61%)
GILD   66.66 (-2.20%)
S&P 500   3,859.18 (+0.10%)
DOW   31,005.34 (+0.15%)
QQQ   329.12 (+0.31%)
AAPL   142.91 (+-0.01%)
MSFT   233.58 (+1.76%)
FB   282.96 (+1.78%)
GOOGL   1,908.93 (+0.77%)
AMZN   3,331.01 (+1.12%)
TSLA   888.62 (+0.89%)
NVDA   539.09 (-1.29%)
BABA   264.12 (+1.05%)
CGC   35.33 (+7.35%)
GE   11.56 (+5.19%)
MU   80.50 (-0.96%)
AMD   94.93 (+0.85%)
NIO   59.71 (-0.47%)
T   29.67 (+1.92%)
F   11.16 (-1.15%)
ACB   10.68 (+5.12%)
BA   202.67 (-0.34%)
DIS   169.83 (-1.20%)
NFLX   560.16 (+0.61%)
GILD   66.66 (-2.20%)
Log in
NASDAQ:EVGN

Evogene SEC Filings & 10K Form

$7.03
+0.43 (+6.52 %)
(As of 01/26/2021 02:02 PM ET)
Add
Compare
Today's Range
$6.88
Now: $7.03▼
$7.50
50-Day Range
$3.67
MA: $4.84▼
$6.24
52-Week Range
$0.75
Now: $7.03▼
$7.30
Volume45,616 shs
Average Volume2.17 million shs
Market Capitalization$181.02 million
P/E RatioN/A
Dividend YieldN/A
Beta1.43

SEC Filings

Evogene (NASDAQ:EVGN) SEC Filings

DateFilerForm TypeView
01/21/2021
4:00 PM		ALPHA CAPITAL ANSTALT (Filed by)
Evogene (Subject)
Form SC 13G/A
01/14/2021
4:21 PM		Evogene (Filer)
Form 424B5
01/14/2021
4:02 PM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/31/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/29/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/23/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/15/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/10/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/02/2020
4:27 PM		Evogene (Filer)
Form 424B5
11/02/2020
12:22 PM		ALPHA CAPITAL ANSTALT (Filed by)
Evogene (Subject)
Form SC 13G/A
10/30/2020
4:00 PM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/20/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/13/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2020
12:53 PM		ARK Investment Management LLC (Filed by)
Evogene (Subject)
Form SC 13G
09/17/2020
7:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/15/2020
3:15 PM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/10/2020
11:15 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/08/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/02/2020
3:20 PM		Evogene (Filer)
Form 424B5
09/02/2020
8:20 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/01/2020
3:32 PM		ALPHA CAPITAL ANSTALT (Filed by)
Evogene (Subject)
Form SC 13G
09/01/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/10/2020
11:15 PM		Evogene (Filer)
Form EFFECT
08/05/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/05/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2020
3:00 PM		Evogene (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
05/28/2020
6:19 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/05/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2020
7:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/04/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2020
10:37 AM		Evogene (Subject)
Phoenix Holdings Ltd. (Filed by)
Form SC 13G/A
02/11/2020
5:25 AM		Evogene (Subject)
UBS Group AG (Filed by)
Form SC 13G/A
02/06/2020
6:04 AM		Evogene (Subject)
Migdal Insurance & Financial Holdings Ltd. (Filed by)
Form SC 13G
01/28/2020
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2019
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2019
6:04 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2019
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2019
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/22/2019
9:30 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2019
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2019
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2019
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2019
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2019
6:02 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2019
9:31 AM		Evogene (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/15/2019
5:12 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2019
3:37 PM		Evogene (Subject)
Senvest Management, LLC (Filed by)
Form SC 13G
04/03/2019
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/18/2019
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2019
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2019
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/15/2019
1:16 PM		Evogene (Subject)
UBS Group AG (Filed by)
Form SC 13G/A
02/14/2019
11:45 AM		Evogene (Subject)
Phoenix Holdings Ltd. (Filed by)
Form SC 13G/A
02/14/2019
5:20 AM		Evogene (Subject)
Migdal Insurance & Financial Holdings Ltd. (Filed by)
Form SC 13G
02/12/2019
9:36 AM		Evogene (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
02/04/2019
6:02 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2019
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/29/2019
1:44 PM		Evogene (Subject)
Harel Insurance Investments & Financial Services Ltd. (Filed by)
Form SC 13G/A
11/27/2018
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/19/2018
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2018
6:01 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2018
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2018
6:03 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2018
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2018
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/14/2018
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2018
6:01 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2018
5:16 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2018
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/30/2018
5:14 AM		Evogene (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/28/2018
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/27/2018
6:00 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2018
5:11 AM		Evogene (Subject)
Phoenix Holdings Ltd. (Filed by)
Form SC 13G/A
02/14/2018
3:10 PM		Evogene (Subject)
WADDELL & REED FINANCIAL INC (Filed by)
Form SC 13G/A
02/13/2018
3:43 PM		Evogene (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G
02/13/2018
2:38 PM		Evogene (Subject)
UBS Group AG (Filed by)
Form SC 13G
02/12/2018
2:31 PM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2018
2:17 PM		Evogene (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G
02/12/2018
6:07 AM		Evogene (Subject)
Psagot Investment House Ltd. (Filed by)
Form SC 13G/A
02/01/2018
5:44 AM		Evogene (Subject)
Harel Insurance Investments & Financial Services Ltd. (Filed by)
Form SC 13G/A
01/22/2018
5:32 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2018
5:31 AM		Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2018
5:12 AM		Evogene (Subject)
Migdal Insurance & Financial Holdings Ltd. (Filed by)
Form SC 13G
This page was last updated on 1/26/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.